Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Liver Neoplasms and MDM2[original query] |
|---|
| Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma. The International journal of biological markers 0 26 (4): 229-33. Ezzikouri Sayeh, Essaid El Feydi Abdellah, Afifi Rajae, Benazzouz Mustapha, Hassar Mohammed, Pineau Pascal, Benjelloun Souma |
| Association between MDM2 promoter SNP309 T/G polymorphism and liver cancer risk - a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2012 13 (6): 6. Ma HB, Huang T, Han F, Chen WY |
| Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma. Protein & cell 2013 Jan 4 (1): 1. Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W |
| Association between murine double minute 2 T309G polymorphism and risk of liver cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Nov 35 (11): 11353-7. Tang Tao, Song Xin, Yang Zhiying, Huang Linping, Wang Wenyue, Tan Haido |
| MDM2 285G>C and 344T>A gene variants and their association with hepatocellular carcinoma: a Moroccan case-control study. Infectious agents and cancer 2014 9 (1): 11. Rebbani Khadija, Ezzikouri Sayeh, Marchio Agnès, Kandil Mostafa, Pineau Pascal, Benjelloun Souma |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 11, 2023
- Content source: